ALNYLAM PHARMACEUTICALS, INC.

Pharmaceutical Preparations | SIC: 2834
Phone: (617) 551-8200
CIK: 0001178670
EIN: 770602661
State Location: MA
Tickers:
  • Nasdaq:ALNY

Form: DEFA14A

Filing Date: 06 Apr 2026
Report Date:
Accepted: 06 Apr 2026 02:31 p.m.
Accession Number: 0001628280-26-023924
Act: 34
File Number: 001-36407
Film Number: 26841658

Documents

Primary Document: DEFA14A
Accepted: 06 Apr 2026 02:31 p.m.